[Federal Register Volume 62, Number 185 (Wednesday, September 24, 1997)]
[Notices]
[Page 49989]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-25267]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
Advisory Committee; Notice of Meeting
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
This notice announces a forthcoming meeting of a public advisory
committee of the Food and Drug Administration (FDA). At least one
portion of the meeting will be closed to the public.
Name of Committee: Vaccines and Related Biological Products
Advisory Committee.
General Function of the Committee: To provide advice and
recommendations to the agency on FDA regulatory issues.
Date and Time: The meeting will be held on October 16, 1997, 12:30
p.m. to 3:15 p.m.
Location: Food and Drug Administration, Bldg. 29, conference room
121, 8800 Rockville Pike, Bethesda, MD. This meeting will be held by a
telephone conference call. A speaker telephone will be provided in the
conference room to allow public participation in the meeting.
Contact Person: Nancy T. Cherry or Denise H. Royster, Center for
Biologics Evaluation and Research (HFM-21), Food and Drug
Administration, 1401 Rockville Pike, Rockville, MD 20852, 301-827-0314,
or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-
0572 in the Washington, DC area), code 12388. Please call the
Information Line for up-to-date information on this meeting.
Agenda: The committee will discuss the intramural scientific
program of the Laboratory of Pertussis.
Procedure: On October 16, 1997, from 12:30 p.m. to 1:15 p.m., and
2:15 p.m. to 3:15 p.m., the meeting is open to the public. Interested
persons may present data, information, or views, orally or in writing,
on issues pending before the committee. Written submissions may be made
to the contact person by October 9, 1997. Oral presentations from the
public will be scheduled between approximately 2:15 p.m. and 3:15 p.m.
Time allotted for each presentation may be limited. Those desiring to
make formal oral presentations should notify the contact person before
October 9, 1997, and submit a brief statement of the general nature of
the evidence or arguments they wish to present, the names and addresses
of proposed participants, and an indication of the approximate time
requested to make their presentation.
Closed Committee Deliberations: On October 16, 1997, from 1:15 p.m.
to 2:15 p.m., the meeting will be closed to permit discussion where
disclosure would constitute a clearly unwarranted invasion of personal
privacy (5 U.S.C. 552b(c)(6)). The meeting will be closed to discuss
personal information concerning individuals associated with the
research program.
Notice of this meeting is given under the Federal Advisory
Committee Act (5 U.S.C. app. 2).
Dated: September 16, 1997.
Michael A. Friedman,
Deputy Commissioner for Operations.
[FR Doc. 97-25267 Filed 9-23-97; 8:45 am]
BILLING CODE 4160-01-F
